Replies to post #11733 on DNAprint Genomics (DNAG)

[DougS.]

I'll be interested to see what you find. IMO - Bayer, AstraZeneca and all the others parter with GNSC for the same reason. They get access to a haplotype map for chump change and they don't have to give up much in return. Wether it's useful to them or not I have no idea.

[80spitfire]

OT-Ming,

How do you see the buyout of LARK fitting into the picture?

TIA,

Spitfire